Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. - Wikidata - awgldk - TriplyDB

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.

http://www.wikidata.org/entity/Q33888706

about

Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.The prognostic and risk-stratified value of heart-type fatty-acid-binding protein in community acquired pneumonia in emergency department.Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia.Pro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar prospective observational study Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients.Optimizing triage and hospitalization in adult general medical emergency patients: the triage project Hyponatremia and anti-diuretic hormone in Legionnaires' disease.Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in "Real Life", an Observational Quality Control Survey.Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement.Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study The TRIAGE-ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency Department - Development Based on a Multi-National, Prospective, Observational Study Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio.Adrenomedullin for Risk Stratification of Emergency Patients With Nonspecific Complaints: An Interventional Multicenter Pilot Study.Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.Prediction of prognosis by markers in community-acquired pneumonia.The role of immune and metabolic biomarkers for improved management of sepsis patients.Biomarkers for community-acquired pneumonia in the emergency department.Community-acquired pneumonia: An overview.Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia.Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies.MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children.Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity.Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia.The potential impact of biomarker-guided triage decisions for patients with urinary tract infections.Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.Review article: Sepsis in the emergency department - Part 2: Investigations and monitoring.The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.

P2860

Q33869378-3C6DDE90-DFD0-44CB-978E-66906B995A6C Q34014357-B93724D4-0AA2-4E45-8E50-E267D864D02E Q34024693-97825C35-7057-4BA7-8071-D6BB773067D9 Q34346628-F8ADAB91-CBCD-47AF-8A25-D9D98C709122 Q34558232-36286681-2229-4592-802D-97872AB5EE69 Q34791783-27C61635-3FA4-497F-B465-76B232C8A214 Q35065229-5756DA31-E742-4B07-B634-02E862A47D64 Q35648136-BEB90833-ED15-4E5D-9A72-3C4F4E3274B9 Q35667182-466040D2-66F6-4F80-809E-C2348C198C5C Q35858729-81828A72-0EA0-4944-99A3-59C51573E9E5 Q36031663-9A879C9D-A2CE-4382-986F-58869B6B8C84 Q36222704-D72B0108-5773-4D39-9555-228010C96DB2 Q36231380-5FE2F2B6-55AF-45DD-902C-9DE268BA8ADE Q36310667-D2F20091-13E3-496A-963A-AB087A173A0B Q36445043-21CCF8AB-6762-4CF3-8E8E-0A1C303A7130 Q36735014-229AE896-A18B-4CAD-8CF2-A425D01090BE Q37209299-4D3E6E52-C7C4-4BEE-865A-FCA900D80D01 Q38040130-99779E91-7DCB-4DDB-A8B6-B0056E96C5EB Q38140013-64E7889D-33AD-4F20-99BC-68FE4B5F6287 Q38234688-6D7BE115-BE66-4538-8C60-2D00C5E381F6 Q38263097-E6C0BC76-E6C7-4386-A228-A919C51DF678 Q38557188-980A56B7-385B-4E3A-8FD7-3E03F7B0E0E2 Q40147071-DB4BD03B-22C8-4842-8800-B55557654E59 Q40262183-D365410B-0BEE-4F6A-9D3C-5DAA2C3E9FE9 Q40989235-AED631C5-5DFF-4B5F-AC43-46BA68B78B65 Q41368070-96C33B1B-F89F-4215-9D6B-959316A75994 Q41658608-4B07F6A8-73D5-48B4-B431-1FFC8B9DCBC7 Q42321773-B44711B1-56BF-4004-B854-2941EE9E29E0 Q43854895-552C7142-27D1-4313-94A0-491D97A8E968 Q44216994-65788C1E-9EDA-413D-BFE7-857AC57C5085 Q45222877-1AD096DB-9566-43EF-A5E6-3BACCF45CAF8 Q47159484-35742961-7F0E-44DE-9199-57C31C6A9D6C Q47728125-AAA48673-9DE9-49FC-BD81-959EB7A4C98D Q55014096-48BFFF2B-35A1-4090-B781-BAE0D6DF16A5

P2860

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.

http://www.wikidata.org/entity/Q33888706

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Enhancement of CURB65 score wi ...... ation of a clinical algorithm.

@ast

Enhancement of CURB65 score wi ...... ation of a clinical algorithm.

@en

type

label

Enhancement of CURB65 score wi ...... ation of a clinical algorithm.

@ast

Enhancement of CURB65 score wi ...... ation of a clinical algorithm.

@en

prefLabel

Enhancement of CURB65 score wi ...... ation of a clinical algorithm.

@ast

Enhancement of CURB65 score wi ...... ation of a clinical algorithm.

@en

P1433

Q33888706-EE290865-B022-4397-8B84-52F3F4A6D5EC

P1476

Q33888706-27FDE269-D5F8-4408-A08C-91D31A85AC84

P2093

Q33888706-2B1DC186-11EF-4111-93F7-FDF9F7AC1BA5

Q33888706-3029912E-ACF6-4535-8D58-21B3FF9C1303

Q33888706-5029B534-2B72-47B4-BED4-9784A5F907AB

Q33888706-5B372051-631F-40B3-88C7-55766AA53974

Q33888706-74E2AB39-9611-46BA-B4AD-DB1921A006C1

Q33888706-9C6E9AC0-9E21-4C6F-944E-7CCF55DA83D1

Q33888706-B8E5D71B-28F2-48CD-A6C8-1107888AB6ED

Q33888706-D6DFCFE2-02E3-4164-9999-0E61283273F8

Q33888706-E44658BE-3A04-41A2-892B-639A87F16B3C

Q33888706-FAFA0F55-93E6-4BE8-88C3-DC348AB58851

P2860

Q33888706-143360C4-0668-4AB0-A36F-C8DA8A5BC424

Q33888706-14412CA2-BC0A-4336-8D71-05F50B955FB9

Q33888706-19F2AB89-93DE-46D0-9E51-A2388DDFAC80

Q33888706-24635540-1718-4BB2-B6AB-E1B5C2419EEA

Q33888706-258767E7-D3C8-497A-9F40-08E667AF04F1

Q33888706-31D5CAA2-10ED-489B-B54B-0F5FFB8F77D3

Q33888706-35147D8F-A13B-4C53-9A2B-692A061D5C60

Q33888706-4043436B-3C85-4F65-866E-E526F5BB28CD

Q33888706-4E19DFF8-14D8-4FED-9E95-858086DE39D1

Q33888706-5EC858D5-11DE-405C-B1B1-19DBAB3DE6D3

P2888

Q33888706-2EFBBC13-29FB-404C-A1C7-678BAB36E03F

P304

Q33888706-4B868EEC-6A1D-4574-BE5F-E6E38E5CB6C8

P31

Q33888706-3F3D9188-E455-4F09-A550-E6C1790E4A1E

P356

Q33888706-17C5ECC0-F1B8-4CF0-BE05-CD8A30762B7F

P478

Q33888706-1DFBF67E-C579-4EC5-A615-4C5F801A350E

P50

Q33888706-0108F3D5-3E4A-4338-B6A2-1B70C99ADCF4

P577

Q33888706-328F38DB-116E-4AAD-B888-7E7E714B371D

P5875

Q33888706-D4AD950F-248A-4743-BFF7-3851A187B0D1

P6179

Q33888706-5B0D4C7C-7175-4A78-9CF3-CC9988450ED6

P698

Q33888706-03B098F1-F1F6-439C-8442-2C6FC9D193BD

P932

Q33888706-BF19E2E6-5996-4CE4-B58B-E50610F9B828

P356

1471-2334-11-112

P1433

BMC Infectious Diseases

P1476

Enhancement of CURB65 score wi ...... vation of a clinical algorithm

@en

P2093

Barbara Reutlinger

http://www.w3.org/2001/XMLSchema#string

Beat Mueller

http://www.w3.org/2001/XMLSchema#string

Frank Dusemund

http://www.w3.org/2001/XMLSchema#string

Kristina Rüegger

http://www.w3.org/2001/XMLSchema#string

Philipp Schuetz

http://www.w3.org/2001/XMLSchema#string

Sarosh Irani

http://www.w3.org/2001/XMLSchema#string

Thomas Bregenzer

http://www.w3.org/2001/XMLSchema#string

Ulrich Buergi

http://www.w3.org/2001/XMLSchema#string

Werner C Albrich

http://www.w3.org/2001/XMLSchema#string

Werner Zimmerli

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

Determinants for hospitalization in " low-risk" community acquired pneumonia

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial

A prediction rule to identify low-risk patients with community-acquired pneumonia

Performance of severity of illness scoring systems in emergency department patients with infection

Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong.

P2888

1471-2334-11-112

P304

112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-11-112

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Mirjam Christ-Crain

P577

2011-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51095622

http://www.w3.org/2001/XMLSchema#string

P6179

1028398900

http://www.w3.org/2001/XMLSchema#string

P698

21539743

http://www.w3.org/2001/XMLSchema#string

P932

3119069

http://www.w3.org/2001/XMLSchema#string